APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Aptevo Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.60−0.02 (-1.23%)
Close on Oct 19, 2026
- Market cap
- $1.91M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 26, 2026(first seen in filings) | 1-for-18 reverse | Earlier per-share figures multiplied by 18 |
| Dec 30, 2025 | 1-for-18 reverse | Earlier per-share figures multiplied by 18 |
| May 27, 2025 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Dec 4, 2024 | 1-for-37 reverse | Earlier per-share figures multiplied by 37 |
| Dec 2, 2024 | 1-for-37 reverse | Earlier per-share figures multiplied by 37 |
| Mar 6, 2024 | 1-for-44 reverse | Earlier per-share figures multiplied by 44 |
| May 13, 2020(first seen in filings) | 1-for-17.5 reverse | Earlier per-share figures multiplied by 17.5 |
| Mar 27, 2020 | 1-for-14 reverse | Earlier per-share figures multiplied by 14 |